Showing 1 - 10 of 182,144
Even in wealthy economies, access to medicines is increasingly affected by medicine shortages – an issue exacerbated with the onset of the COVID-19 pandemic. The aim of this paper was to examine the extent and nature of medicine shortages in OECD countries (pre-COVID-19) and explore the...
Persistent link: https://www.econbiz.de/10013174584
additional funds, can play in financing health services in India. It formulates an SHI concept and its aims for India and … they offer for India and suggests a suitable design for India. It then estimates the volumes of tax revenues and payroll … contributions that may be obtainable by India through SHI. Towards the end it also outlines some of the important design elements …
Persistent link: https://www.econbiz.de/10013022621
availability of health-related products such as pharmaceuticals, vaccines, and medical equipment. The case for liberalizing trade …
Persistent link: https://www.econbiz.de/10011591118
driving the costs of pharmaceuticals, and develop a structured vector autoregressive (SVAR) model to measure the social rate …-run prices in pharmaceuticals themselves, but with lower long-run prices in the aggregate medical sector which includes … pharmaceuticals as a component part. Further, the TRIPS Agreement and Hatch-Waxman Act to enable generic competition have both been …
Persistent link: https://www.econbiz.de/10014209235
Using administrative data from Hungary, we analyse the effect of general practitioner (GP) care availability on the consumption of antibiotics. We exploit the geographical and time variation in unfilled GP positions as a source of exogenous variation in the availability of primary care....
Persistent link: https://www.econbiz.de/10012011113
We use the geographic distance between a doctor's office and drug company headquarters to instrument for the likelihood of pecuniary transfers, such as meals or speaking fees. Doctors tilt prescriptions in favor of the paying firm's drugs, shifting away from both branded and generic substitutes....
Persistent link: https://www.econbiz.de/10013063438
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets that control adverse selection and assure adequate access and coverage. The focus of this paper is on the ability of consumers to evaluate and optimize...
Persistent link: https://www.econbiz.de/10009666978
This paper examines how physicians in China respond to a pay-for-performance scheme that mismeasures performance. In 2005, China imposed a policy that penalizes hospitals with high drug sale percentage in the total revenue, with the intent to decrease drug expenditure. Using a unique...
Persistent link: https://www.econbiz.de/10010361468
The introduction of antibiotics as a medical treatment after World War II helped to dramatically increase life expectancy in the industrialized world. As a consequence of over-prescription the last decades ave however seen a sharp increase in prevalence of multi-resistant bacteria, disarming...
Persistent link: https://www.econbiz.de/10009793592